060 Integrated Safety of Ixekizumab in Patients With Moderate-To-Severe Psoriasis: Results From a Pooled Analysis of 7 Clinical Trials
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2016.06.077
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2016
Authors
Publisher
Elsevier BV